/Bank%20Of%20New%20York%20Mellon%20Corp%20location%20sign-by%20JHVEPhoto%20via%20Shutterstock.jpg)
With a market cap of $64.4 billion, The Bank of New York Mellon Corporation (BK) is a leading global financial services company. It provides a comprehensive range of investment and wealth management, securities services, and market solutions to institutions, corporations, and high-net-worth individuals worldwide.
Companies worth more than $10 billion are generally labeled as “large-cap” stocks and BNY Mellon fits this criterion perfectly. Operating through multiple business segments, BNY Mellon serves as a critical partner for clients managing and servicing investments across diverse markets.
Shares of the Cleveland, OhioNew York-based company pulled back marginally from its 52-week high of $90.63. BNY Mellon’s shares have risen 7.1% over the past three months, lagging behind the Nasdaq Composite’s ($NASX) 12.2% return over the same time frame.
In the longer term, BK stock is up 17.4% on a YTD basis, exceeding NASX’s 1.5% rise. Moreover, shares of BNY Mellon have surged 48.6% over the past 52 weeks, outperforming the nearly 14% return of the NASX over the same time frame.
Despite few fluctuations, the stock has been trading above its 50-day and 200-day moving averages since last year.
Shares of BK rose 1.4% on Apr. 11 after the company reported stronger-than-expected Q1 2025 results, including a 6% year-over-year revenue increase to $4.8 billion, beating the Street estimate. Adjusted EPS came in at $1.58, surpassing the consensus, while adjusted profit jumped 17% to $1.2 billion. Investor sentiment was further boosted by an 11% rise in net interest income to $1.2 billion and a 9% increase in assets under custody/administration to $53.1 trillion.
In addition, BK has outperformed its rival, JPMorgan Chase & Co. (JPM). JPM stock has soared 34.1% over the past 52 weeks and 11.7% on a YTD basis.
Despite the stock’s strong performance over the past year, analysts remain cautiously optimistic on BK. The stock has a consensus rating of “Moderate Buy” from the 17 analysts covering the stock, and as of writing, it is trading below the mean price target of $93.19.
